Market Overview

Morning Market Movers

Share:
Related
Stocks Hitting 52-Week Highs
Benzinga's Top Pre-Market Gainers
Related BIOL
Former Biolase CEO Announces Resignation From Biolase Board
Former CEO of Biolase Sends Letter To Correct Wrongful Allegations
BIOLASE's (BIOL) CEO Jeff Nugent on Q4 2014 Results - Earnings Call Transcript (Seeking Alpha)

Sarepta Therapeutics (NASDAQ: SRPT) shares advanced 100.20% to $30.01 at 9:45 am. Sarepta Therapeutics reported that treatment with its eteplirsen met its primary endpoint in a Phase IIb extension trial in Duchenne muscular dystrophy patients.

BIOLASE (NASDAQ: BIOL) climbed 22.29% to $2.03. BIOLASE has received clearance from the FDA and Conformité Européene Mark approval for its EPIC 10™ diode soft tissue laser.

Ocwen Financial (NYSE: OCN) surged 15.40% to $33.42. Ocwen Financial announced its plans to acquire Homeward Residential Holdings from WL Ross & Co LLC.

BioLineRx Ltd (NASDAQ: BLRX) surged 14.84% to $2.9972. BioLineRx shares have dropped 23.91% over the past 52 weeks, while the S&P 500 index has gained 28.63% in the same period.

Posted-In: Morning Market MoversNews Intraday Update Markets Movers

 

Related Articles (BLRX + BIOL)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→